Search

Author/Creator Marquez-Rodas, Ivan

1. Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Issue 3 (29th March 2021)

Authors:
Gonzalez-Cao, Maria; Puertolas, Teresa; Riveiro, Mar; Muñoz-Couselo, Eva; Ortiz, Carolina; Paredes, Roger; Podzamczer, Daniel; Manzano, Jose Luis; Molto, Jose; Revollo, Boris; Carrera, Cristina; Mateu, Lourdes; Fancelli, Sara; Espinosa, Enrique; Clotet, Bonaventura; Martinez-Picado, Javier; Cerez...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immunotherapeutic effects of intratumoral nanoplexed poly I:C. Issue 1 (2nd May 2019)

Authors:
Aznar, M. Angela; Planelles, Lourdes; Perez-Olivares, Mercedes; Molina, Carmen; Garasa, Saray; Etxeberría, Iñaki; Perez, Guiomar; Rodriguez, Inmaculada; Bolaños, Elixabet; Lopez-Casas, Pedro; Rodriguez-Ruiz, Maria E.; Perez-Gracia, Jose L.; Marquez-Rodas, Ivan; Teijeira, Alvaro; Quintero, Marisol...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients. (13th January 2018)

Authors:
Karachaliou, Niki; Gonzalez-Cao, Maria; Crespo, Guillermo; Drozdowskyj, Ana; Aldeguer, Erika; Gimenez-Capitan, Ana; Teixido, Cristina; Molina-Vila, Miguel Angel; Viteri, Santiago; De Los Llanos Gil, Maria; Algarra, Salvador Martin; Perez-Ruiz, Elisabeth; Marquez-Rodas, Ivan; Rodriguez-Abreu, Delv...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 10(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Melanoma and immunotherapy bridge 2015. Issue 1 (July 2016)

Authors:
Nanda, Vashisht; Peng, Weiyi; Hwu, Patrick; Davies, Michael; Ciliberto, Gennaro; Fattore, Luigi; Malpicci, Debora; Aurisicchio, Luigi; Ascierto, Paolo; Croce, Carlo; Mancini, Rita; Spranger, Stefani; Gajewski, Thomas; Wang, Yangyang; Ferrone, Soldano; Vanpouille-Box, Claire; Wennerberg, Erik; Pil...
Journal:
Journal of translational medicine
Issue:
Volume 14:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. Issue 11 (November 2018)

Authors:
Hodi, Frank Stephen; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Cowey, Charles Lance; Lao, Christopher D; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Hill, Andrew; Hogg, David; Marquez-Rodas, Ivan; Jiang, Joel;...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 11(2018)
Page Start:
1480
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172). (November 2019)

Authors:
Schadendorf, Dirk; Ascierto, Paolo A.; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K.; Bafaloukos, Dimitr...
Journal:
European journal of cancer
Issue:
Volume 121(2019)
Page Start:
144
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗